Use of lipid conjugates in cystic fibrosis and applications thereof

Details for Australian Patent Application No. 2006278657 (hide)

Owner Yissum Research Development Company of the Hebrew University of Jerusalem Morria Biopharmaceuticals The Trustees of Columbia University

Inventors Prince, Alice; Yedgar, Saul; Yuval, Cohen

Agent Griffith Hack

Pub. Number AU-B-2006278657

PCT Pub. Number WO2007/019131

Priority 60/704,874 03.08.05 US; 60/780,379 09.03.06 US

Filing date 1 August 2006

Wipo publication date 15 February 2007

Acceptance publication date 28 June 2012

International Classifications

A61K 31/726 - Glycosaminoglycans, i.e. mucopolysaccharides

Event Publications

28 February 2008 PCT application entered the National Phase

  PCT publication WO2007/019131 Priority application(s): WO2007/019131

28 June 2012 Application Accepted

  Published as AU-B-2006278657

25 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006278665-Method and system for determining an electromagnetic response from an earth formation and method of drilling a borehole and method of producing a hydrocarbon fluid

2006278654-Stabilizers for veterinary vaccines